Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Prognosis becomes increasingly worse vs. marrow-confined disease for primary paraskeletal (PS) lesions diagnosis (HR=2.22), secondary PS (HR=3.33), and ultra-high-risk for secondary extramedullary disease (EMD)(HR=8.14).”
Title: Timing and Pattern of Extraosseous Dissemination Are Key Determinants of Survival in Multiple Myeloma
Authors: Mickael Tordjman, Anis Meribout, Amine Geahchan, Ian Bolger, Murat Yuce, Xinran Zhuo, Swathi Pavuluri, Erin Choe, Francisco Restrepo, Allison Yu, Alessia D’Anna, Alessandro Lagana, Kimone Crossley-Brown, Giuseppe Petralia, Sundar Jagannath, Xueyan Mei, Samir Parekh, Bachir Taouli
You can read the Full Article in American Journal of Hematology.
You can find other articles featuring Robert Orlowski on OncoDaily.
